Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.73764 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.86724 | 38 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.86354 | 38 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.82914 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.82099 | 38 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.93738 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.89844 | 37 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.8454 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.84098 | 38 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.87033 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.84459 | 37 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.84239 | 38 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.8518 | 37 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.85282 | 38 |